retatrutide trial results 2025 news for Weight Loss: 2026 Research Reference Retatrutide: Every Clinical Trial Result

Direct answer: Blood tests may identify metabolic, kidney, electrolyte, liver, or pancreatic-enzyme changes, but they cannot rule out every GLP-1 complication

Among these latter, non-alcoholic fatty liver disease (NAFLD), characterized by lipid accumulation in hepatocytes, in the absence of alcohol abuse or other steatogenic factors, is one of the most prevalent

You should also look into underlying GI conditions and drug interactions (such as steroids or laxatives) that could impair absorption

You can also explore our blog for the latest insights on health and wellness topics

10.3390/biom14050593 167 HanrahanJ.SteevesK

Here is an NPR story I was part of a few months back on this same topic